Core A: Administrative Core
Core A: Administrative Core
批准号:
10362704
负责人:
Pawel Kalinski
金额:
$8.95万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
未结题
起止时间:
2020-03-03 至 2026-07-31
关键词:
AcademiaBiotechnologyClinicalClinical ManagementClinical ResearchCommunicationCommunitiesComprehensive Cancer CenterDevelopmentEnsureFoundationsGeneral PopulationGrantHospitalsImmunotherapyInstitutionLaboratoriesLaboratory ResearchMalignant NeoplasmsOccupational activity of managing financesParticipantPreparationPrincipal InvestigatorProgram Research Project GrantsProgram ReviewsProgress ReportsReportingResearchResearch Project GrantsResource SharingSupervisionSystemUnited States National Institutes of HealthUniversitiesVideoconferencingWomanWorkchemokinedata disseminationdata sharingexperiencemeetingsmemberprogramstumor
中文摘要
摘要
管理核心(核心A)将对本P01中提出的研究进行全面监督
计划项目。核心A由本项目的主要研究者Pawel Kalinski博士指导。博士
卡林斯基有直接的工作经验,在两个参与机构,罗斯韦尔公园综合癌症
中心(RPCI;自2017年2月)和匹兹堡大学(2000-2017)。卡林斯基医生会得到
罗斯威尔公园赠款和基金会发展主任朱迪思·爱泼斯坦女士将担任
总体P01项目经理提供项目监督和互动协调,
通讯P01执行委员会将由P01项目的领导人组成,
丹
核心A将负责对本计划项目内的研究进行全面监督,
罗斯韦尔公园和匹兹堡大学,其参与者之间的数据传播和外部
实体,核心的监督,与NCI和内部和外部顾问的互动,沿着
与罗斯韦尔公园和匹兹堡大学的平行项目的互动。核心A将
组织季度会议,沿着年度P01务虚会,审查计划进展。它将
与所有研究项目和这个高度翻译的P01的所有核心密切互动,它将工作
特别是与核心C(临床)密切合作,以确保临床和实验室方面的最佳整合,
这个临床导向的研究项目
行政核心有以下具体目标:1)财务管理和计划赠款
2)协调参与项目的各小组之间的互动和项目会议;
3)与罗斯威尔公园和大学的其他计划项目分享数据和经验。
匹兹堡; 4)将该计划与临床计划和现有共享资源核心整合,
罗斯韦尔公园和匹兹堡大学; 5)协调方案会议和促进
与内部和外部咨询委员会的互动; 5)与NIH/NCI的沟通,包括
编制年度进度报告和最终方案项目报告;以及6)向
罗斯韦尔公园的其他团体,匹兹堡大学,外部合作伙伴和科学界,
马达加斯加国家顶级域名
英文摘要
ABSTRACT
The Administrative Core (Core A) will provide overall oversight of the research proposed within this P01
Program Project. Core A is directed by Dr. Pawel Kalinski, the Principal Investigator of this Program. Dr.
Kalinski has direct work experience at the two participating institutions, Roswell Park Comprehensive Cancer
Center (RPCI; since February 2017) and the University of Pittsburgh (2000-2017). Dr. Kalinski will be assisted
by Ms. Judith Epstein, Director of Grant and Foundation Development at Roswell Park who will serve as the
overall P01 Program Manager providing Program oversight and coordination of interactions and
communications. The P01 Executive Committee will be composed of the leaders of the P01 Projects and
Cores.
Core A will be responsible for the overall supervision of the research within this Program Project performed at
Roswell Park and the University of Pittsburgh, data dissemination between its participants and to outside
entities, oversight of the Cores, the interactions with NCI and the Internal and External Advisors, along with
interactions with parallel program projects at Roswell Park and the University of Pittsburgh. Core A will
organize the quarterly meetings to review of Program progress, along with the Annual P01 Retreats. It will
closely interact with all Research Projects and all Cores of this highly-translational P01, and it will work
particularly closely with Core C (Clinical) to assure optimal integration of the clinical and laboratory aspects of
this clinically-oriented research program.
The Administrative Core has the following Specific Aims: 1) Financial management and Program grant
administration; 2) Coordination of interactions and Program meetings among the groups involved in the
Program; 3) Sharing of data and experience with other Program Projects at Roswell Park and the University of
Pittsburgh; 4) Integration of this Program with the clinical programs and existing shared resource cores at
Roswell Park and the University of Pittsburgh; 5) Coordination of Program meetings and facilitation of
interactions with the Internal and External Advisory Boards; 5) Communication with NIH/NCI, including the
preparation of annual progress reports and the and final Program Project report; and 6) Data dissemination to
other groups at Roswell Park, the University of Pittsburgh, outside partners and the scientific community and
general public.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Targeting the Chemokine System to Sensitize Tumors to Immunotherapy
-
批准号:10362635
-
项目类别:
-
资助金额:$287.59万
-
财政年份:2020
-
负责人:Pawel Kalinski
-
依托单位:
Project 1: Combinatorial adjuvants promote uniform and selective intratumoral CTL infiltration in colorectal cancer
-
批准号:10362700
-
项目类别:
-
资助金额:$50.21万
-
财政年份:2020
-
负责人:Pawel Kalinski
-
依托单位:
IRP-3
-
批准号:10171149
-
项目类别:
-
资助金额:$33.65万
-
财政年份:2013
-
负责人:Pawel Kalinski
-
依托单位:
MHC-Restricted and MHC-Non-Restricted Targeting of Ovarian Cancer by alphaDC1
-
批准号:8485810
-
项目类别:
-
资助金额:$25.2万
-
财政年份:2013
-
负责人:Pawel Kalinski
-
依托单位:
IRP-3
-
批准号:10473682
-
项目类别:
-
资助金额:$32.31万
-
财政年份:2013
-
负责人:Pawel Kalinski
-
依托单位:
Administrative, Statistical, and Regulatory
-
批准号:8518924
-
项目类别:
-
资助金额:$1.93万
-
财政年份:2012
-
负责人:Pawel Kalinski
-
依托单位:
Tumor-Specific Chemokine Modulation in Colorectal Cancer Versus Melanoma
-
批准号:8518921
-
项目类别:
-
资助金额:$1.59万
-
财政年份:2012
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:8248336
-
项目类别:
-
资助金额:$165.18万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:8518920
-
项目类别:
-
资助金额:$15.25万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:8469287
-
项目类别:
-
资助金额:$143.7万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Administrative, Statistical, and Regulatory
-
批准号:7646823
-
项目类别:
-
资助金额:$14.73万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:7813976
-
项目类别:
-
资助金额:$122.96万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Tumor-Specific Chemokine Modulation in Colorectal Cancer Versus Melanoma
-
批准号:7646820
-
项目类别:
-
资助金额:$22.78万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:8045467
-
项目类别:
-
资助金额:$120.41万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
Directing Tumor-specific T cells to Tumors
-
批准号:7633473
-
项目类别:
-
资助金额:$109.12万
-
财政年份:2009
-
负责人:Pawel Kalinski
-
依托单位:
DCs Regulate Chemokine Responsiveness of Melanoma-Specific T Cells
-
批准号:7408308
-
项目类别:
-
资助金额:$15.23万
-
财政年份:2007
-
负责人:Pawel Kalinski
-
依托单位:
Polarized DC as Melanoma Vaccine: Phase 1 Evaluation
-
批准号:6936950
-
项目类别:
-
资助金额:$29.33万
-
财政年份:2005
-
负责人:Pawel Kalinski
-
依托单位:
Polarized DC as Melanoma Vaccine: Phase 1 Evaluation
-
批准号:7060766
-
项目类别:
-
资助金额:$28.64万
-
财政年份:2005
-
负责人:Pawel Kalinski
-
依托单位:
NK CELLS INDUCE DCI-MEDIATED ANTI-TUMOR IMMUNITY
-
批准号:7128909
-
项目类别:
-
资助金额:$33.25万
-
财政年份:2005
-
负责人:Pawel Kalinski
-
依托单位:
Regulation of DC Activity by Memory and Effector CD8+ T Cells
-
批准号:7741148
-
项目类别:
-
资助金额:$26.86万
-
财政年份:2003
-
负责人:Pawel Kalinski
-
依托单位:
海外基金